M
M. G. Schwendinger
Researcher at Goethe University Frankfurt
Publications - 5
Citations - 871
M. G. Schwendinger is an academic researcher from Goethe University Frankfurt. The author has contributed to research in topics: Heteronuclear molecule & Pulse sequence. The author has an hindex of 4, co-authored 4 publications receiving 804 citations.
Papers
More filters
Journal ArticleDOI
A general enhancement scheme in heteronuclear multidimensional NMR employing pulsed field gradients.
Jürgen Schleucher,M. G. Schwendinger,Michael Sattler,Piet O. Schmidt,O. Schedletzky,Steffen J. Glaser,Ole W. Sørensen,Christian Griesinger +7 more
TL;DR: General pulse sequence elements that achieve sensitivity-enhanced coherence transfer from a heteronucleus to protons of arbitrary multiplicity are introduced and incorporated into heteronuclear correlation experiments, in conjunction with coherence selection by the formation of aheteronuclear gradient echo.
Journal ArticleDOI
Novel strategies for sensitivity enhancement in heteronuclear multi—dimensional NMR experiments employing pulsed field gradients
TL;DR: It is shown that in 3D sequences employing several Coherence Order Selective Coherence Transfer (COS-CT) steps, enhancement factors of up to 2 can be achieved, compatible with the use of heteronuclear gradient echoes, yielding spectra with excellent water suppression.
Journal ArticleDOI
PLUSH TACSY: Homonuclear planar TACSY with two-band selective shaped pulses applied to C(α),C' transfer and C (β),C (aromatic) correlations.
Teresa Carlomagno,Marcus Maurer,Michael Sattler,M. G. Schwendinger,Steffen J. Glaser,Christian Griesinger +5 more
TL;DR: A new homonuclear Hartmann-Hahn-type mixing scheme is introduced that effects coherence transfer between resonances in two separated frequency bands and is applied to Cα,C′ transfer and to the transfer between Cβ and aromatic carbon spins.
Journal ArticleDOI
Broadband Heteronuclear Hartmann-Hahn Sequences
Journal ArticleDOI
Abstract 3284: HB-201 and HB-202, an arenavirus-based immunotherapy, induces tumor T cell infiltration in patients with HNSCC and other HPV16+ tumors
Donna W. Edwards,M. G. Schwendinger,Kianoosh Katchar,Katia Schlienger,Klaus Orlinger,Igor Matushansky,Henning Lauterbach +6 more
TL;DR: HB-201 and HB-202, an werenavirus-based immunotherapy, induces tumor T cell infiltration in patients with HNSCC and other HPV16+ tumors and the ability of replicating arenavirus vectors to incorporate a broad range of antigens and the potent T cell inducing capacity provide a strong rationale to apply this novel therapy to other cancers.